Pasterkamp G - Search Results

1

Toll like receptor 4 in atherosclerosis and plaque destabilization.

den Dekker WK, Cheng C, Pasterkamp G, Duckers HJ. den Dekker WK, et al. Among authors: pasterkamp g. Atherosclerosis. 2010 Apr;209(2):314-20. doi: 10.1016/j.atherosclerosis.2009.09.075. Epub 2009 Oct 12. Atherosclerosis. 2010. PMID: 19900676 Review.

2

The adventitia of atherosclerotic coronary arteries frequently contains Chlamydia pneumoniae.

Vink A, Pasterkamp G, Poppen M, Schoneveld AH, de Kleijn DP, Roholl PJ, Fontijn J, Plomp S, Borst C. Vink A, et al. Among authors: pasterkamp g. Atherosclerosis. 2001 Jul;157(1):117-22. doi: 10.1016/s0021-9150(00)00715-2. Atherosclerosis. 2001. PMID: 11427210

3

In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions.

Vink A, Schoneveld AH, van der Meer JJ, van Middelaar BJ, Sluijter JP, Smeets MB, Quax PH, Lim SK, Borst C, Pasterkamp G, de Kleijn DP. Vink A, et al. Among authors: pasterkamp g. Circulation. 2002 Oct 8;106(15):1985-90. doi: 10.1161/01.cir.0000032146.75113.ee. Circulation. 2002. PMID: 12370224

4

Toll-like receptor 4 is involved in outward arterial remodeling.

Hollestelle SC, De Vries MR, Van Keulen JK, Schoneveld AH, Vink A, Strijder CF, Van Middelaar BJ, Pasterkamp G, Quax PH, De Kleijn DP. Hollestelle SC, et al. Among authors: pasterkamp g. Circulation. 2004 Jan 27;109(3):393-8. doi: 10.1161/01.CIR.0000109140.51366.72. Epub 2003 Dec 29. Circulation. 2004. PMID: 14699006

5

IgM antibody level against proinflammatory bacterial peptidoglycan is inversely correlated with extent of atherosclerotic disease.

Nijhuis MM, van der Graaf Y, Melief MJ, Schoneveld AH, de Kleijn DP, Laman JD, Pasterkamp G; SMART Studygroup. Nijhuis MM, et al. Among authors: pasterkamp g. Atherosclerosis. 2004 Apr;173(2):245-51. doi: 10.1016/j.atherosclerosis.2003.12.005. Atherosclerosis. 2004. PMID: 15064098 Free article.

6

Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease.

Pasterkamp G, Van Keulen JK, De Kleijn DP. Pasterkamp G, et al. Eur J Clin Invest. 2004 May;34(5):328-34. doi: 10.1111/j.1365-2362.2004.01338.x. Eur J Clin Invest. 2004. PMID: 15147329 Review.

7

Functional role for toll-like receptors in atherosclerosis and arterial remodeling.

Vink A, de Kleijn DP, Pasterkamp G. Vink A, et al. Among authors: pasterkamp g. Curr Opin Lipidol. 2004 Oct;15(5):515-21. doi: 10.1097/00041433-200410000-00004. Curr Opin Lipidol. 2004. PMID: 15361786 Review.

8

Levels of extra domain A containing fibronectin in human atherosclerotic plaques are associated with a stable plaque phenotype.

van Keulen JK, de Kleijn DP, Nijhuis MM, Busser E, Velema E, Fijnheer R, van der Graaf Y, Moll FL, de Vries JP, Pasterkamp G. van Keulen JK, et al. Among authors: pasterkamp g. Atherosclerosis. 2007 Nov;195(1):e83-91. doi: 10.1016/j.atherosclerosis.2007.03.014. Epub 2007 Apr 9. Atherosclerosis. 2007. PMID: 17416372

9

Activation of the innate immune system in atherosclerotic disease.

Oude Nijhuis MM, van Keulen JK, Pasterkamp G, Quax PH, de Kleijn DP. Oude Nijhuis MM, et al. Among authors: pasterkamp g. Curr Pharm Des. 2007;13(10):983-94. doi: 10.2174/138161207780487593. Curr Pharm Des. 2007. PMID: 17430162 Review.

10

Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve.

Versteeg D, Hoefer IE, Schoneveld AH, de Kleijn DP, Busser E, Strijder C, Emons M, Stella PR, Doevendans PA, Pasterkamp G. Versteeg D, et al. Among authors: pasterkamp g. Heart. 2008 Jun;94(6):770-6. doi: 10.1136/hrt.2007.117259. Epub 2007 Aug 8. Heart. 2008. PMID: 17686802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

598 results

Search Page

Filters